LGR5 and cancer: This does not refute the central role of CSCs and their relevance as targets for curative cancer therapy development, given that, as in the normal intestinal epithelium, in neoplastic lesions, Lgr5+ cells can be rapidly replenished by dedifferentiation of Lgr5− cells after Lgr5+ cell damage or ablation [15,16].